Who is sponsoring NCT06086210?

NCT06086210 is sponsored by Gulsah Celik.

What drugs are being tested in NCT06086210?

Interventions in NCT06086210: Low-level laser therapy, Sham.

What condition does NCT06086210 study?

NCT06086210 studies Ulnar Nerve Entrapment at Elbow.

Is NCT06086210 still recruiting?

NCT06086210 is currently completed. Last updated 17 October 2023.

Last reviewed 2023-10-17 · How we verify

NCT06086210

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Efficacy of Low Level Laser Therapy in Ulnar Neuropathy at the Elbow

Completed NA Last updated 17 October 2023

What this trial tests

NA trial testing Low-level laser therapy in Ulnar Nerve Entrapment at Elbow in 68 participants. Completed in 1 October 2023.

Timeline

1 October 2022

Primary endpoint
1 May 2023

1 October 2023

Quick facts

Lead sponsor	Gulsah Celik
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	68
Start date	1 October 2022
Primary completion	1 May 2023
Estimated completion	1 October 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Low-level laser therapy
Sham

Conditions studied

Ulnar Nerve Entrapment at Elbow — all drugs for Ulnar Nerve Entrapment at Elbow →

Sponsor

Gulsah Celik

Who can join

Adults 18 to 60, any sex, with Ulnar Nerve Entrapment at Elbow. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is, to demonstrate the effectiveness of low-level laser therapy on symptoms, clinical and electrophysiological parameters in elbow ulnar neuropathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Low-level laser therapy

Trials testing the same drug.

NCT07260994 — Comparative Effect of High-Level Versus Low-Level Laser Therapy on Nerve Root Function Among Healthy Young Adults: A Ran · NA · not yet recruiting
NCT06487338 — Effect of Low-level Laser Therapy Versus Shock Wave Therapy on Pain and Function in Patients With Chronic Non-specific L · NA · completed
NCT06348849 — The Desensitising Effect of Nanosilver Fluoride in Molar-Incisor Hypomineralisation · Phase 2, PHASE3 · completed
NCT06074120 — Low-level Laser Therapy in Genitourinary Symptoms of Menopause · NA · completed
NCT06220786 — Low Level Laser Therapy for Better Wound Healing · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06086210 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gulsah Celik
Last refreshed: 17 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06086210.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing